|

Diabetes Clinical Trials in Kansas City, MO

29 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 YearsN/A<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Phase 3<1 mi
FSL2 Post Approval Study for Pediatric and Young Adults Patients—<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2<1 mi
Type 1 Diabetes Extension Study—<1 mi
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney DiseasePhase 2<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesPhase 2<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2<1 mi
TrialNet Pathway to Prevention of T1D—<1 mi
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor AgonistPhase 2<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 3<1 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesPhase 3<1 mi
Registry for Stage 2 Type 1 Diabetes—<1 mi
Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age FamiliesN/A<1 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseasePhase 2<1 mi
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)N/A<1 mi
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)Phase 1<1 mi
Bionic Pancreas in CFRDPhase 3<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)Phase 3<1 mi
Social Determinants and a Diabetes Prevention Program Tailored for African AmericansPhase 2<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing DialysisPhase 2/3<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesPhase 23 mi
Mitigating the Pro-inflammatory Phenotype of ObesityPhase 13 mi
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)Phase 23 mi
Rural Alliance for Diabetes PreventionN/A3 mi
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II DiabetesPhase 43 mi
Fenofibrate for Prevention of DR WorseningPhase 38 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesPhase 313 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.